
Investor Presentation evening for Venn Life Sciences 22nd Sept
Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, will be reporting its interim results